Cargando…
Non-Apical Membrane Antigen 1 (AMA1) IgGs from Malian Children Interfere with Functional Activity of AMA1 IgGs as Judged by Growth Inhibition Assay
BACKGROUND: Apical membrane antigen 1 (AMA1) is one of the best-studied blood-stage malaria vaccine candidates. When an AMA1 vaccine was tested in a malaria naïve population, it induced functionally active antibodies judged by Growth Inhibition Assay (GIA). However, the same vaccine failed to induce...
Autores principales: | Miura, Kazutoyo, Perera, Suwani, Brockley, Sarah, Zhou, Hong, Aebig, Joan A., Moretz, Samuel E., Miller, Louis H., Doumbo, Ogobara K., Sagara, Issaka, Dicko, Alassane, Ellis, Ruth D., Long, Carole A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113848/ https://www.ncbi.nlm.nih.gov/pubmed/21695140 http://dx.doi.org/10.1371/journal.pone.0020947 |
Ejemplares similares
-
Phase 1 Study of a Combination AMA1 Blood Stage Malaria Vaccine in Malian Children
por: Dicko, Alassane, et al.
Publicado: (2008) -
Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult Malians
por: Dicko, Alassane, et al.
Publicado: (2007) -
Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
por: Ouattara, Amed, et al.
Publicado: (2010) -
Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
por: Thera, Mahamadou A., et al.
Publicado: (2008) -
IgGs drive COVID-19 myeloid hyperinflammation
por: Park, Matthew D.
Publicado: (2020)